Harrow (HROW) Preferred Dividend Payments (2012 - 2021)
Harrow (HROW) recorded quarterly Preferred Dividend Payments of $472000.0 in Q2 2021, up 136.0% quarter-over-quarter from $200000.0 in Q2 2012.
Harrow (HROW) Preferred Dividend Payments (2012 - 2021) Analysis & Trends
Harrow's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $472000.0 for Q2 2021.
- In Q2 2021, Preferred Dividend Payments changed N/A year-over-year to $472000.0; the TTM figure through Dec 2021 stood at $472000.0 (changed N/A YoY), while the FY2021 annual figure was $472000.0, changed N/A from the prior year.
- Preferred Dividend Payments was $472000.0 for Q2 2021 at Harrow, up from $200000.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $472000.0 in Q2 2021 to a low of $472000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 472,000.00 |
| Jun 30, 2012 | 200,000.00 |